‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses

ABSTRACT Background In the UK's National Health Service (NHS), there is specific psychosocial care offered to people with genetic cancer risk conditions but not morphological cancer risk conditions. As researchers develop new ways to diagnose morphological risk conditions, including precancers...

Full description

Saved in:
Bibliographic Details
Main Author: Elspeth Davies
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Medicine
Online Access:https://doi.org/10.1002/cam4.70607
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589775377268736
author Elspeth Davies
author_facet Elspeth Davies
author_sort Elspeth Davies
collection DOAJ
description ABSTRACT Background In the UK's National Health Service (NHS), there is specific psychosocial care offered to people with genetic cancer risk conditions but not morphological cancer risk conditions. As researchers develop new ways to diagnose morphological risk conditions, including precancers and in situ cancers, it is important to consider the psychosocial care that those diagnosed might require. Objectives This study compares the National Institute for Health and Care Excellence's guidelines for BRCA1/2, which are genetic risk conditions, and Barrett's oesophagus (BO), a morphological risk condition. It then theorises reasons for the similarities and differences made visible by this comparative work. Methods The author completed an in‐depth analysis of two sets of NICE guidelines, before carrying out a review of historical and social scientific literature on cancer risk to offer potential explanations for the disparities identified. Results The ‘right not to know’ is protected in the case of BRCA1/2 diagnoses, but not BO. Additionally, specialist counselling is required for people receiving diagnoses of genetic risk but not offered for those diagnosed with morphological risk conditions. The paper offers four possible reasons for these disparities, concluding that they appear to be in large part due to historic genetic exceptionalism, rather than differences in patients' needs. Conclusion There may be a need to consider offering further psychosocial care to people with morphological risk conditions like BO. Lessons might be learnt from the field of genetic counselling.
format Article
id doaj-art-8563246e145c491fb6ae096e11016f2c
institution Kabale University
issn 2045-7634
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-8563246e145c491fb6ae096e11016f2c2025-01-24T08:46:07ZengWileyCancer Medicine2045-76342025-01-01142n/an/a10.1002/cam4.70607‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk DiagnosesElspeth Davies0Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UKABSTRACT Background In the UK's National Health Service (NHS), there is specific psychosocial care offered to people with genetic cancer risk conditions but not morphological cancer risk conditions. As researchers develop new ways to diagnose morphological risk conditions, including precancers and in situ cancers, it is important to consider the psychosocial care that those diagnosed might require. Objectives This study compares the National Institute for Health and Care Excellence's guidelines for BRCA1/2, which are genetic risk conditions, and Barrett's oesophagus (BO), a morphological risk condition. It then theorises reasons for the similarities and differences made visible by this comparative work. Methods The author completed an in‐depth analysis of two sets of NICE guidelines, before carrying out a review of historical and social scientific literature on cancer risk to offer potential explanations for the disparities identified. Results The ‘right not to know’ is protected in the case of BRCA1/2 diagnoses, but not BO. Additionally, specialist counselling is required for people receiving diagnoses of genetic risk but not offered for those diagnosed with morphological risk conditions. The paper offers four possible reasons for these disparities, concluding that they appear to be in large part due to historic genetic exceptionalism, rather than differences in patients' needs. Conclusion There may be a need to consider offering further psychosocial care to people with morphological risk conditions like BO. Lessons might be learnt from the field of genetic counselling.https://doi.org/10.1002/cam4.70607
spellingShingle Elspeth Davies
‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
Cancer Medicine
title ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
title_full ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
title_fullStr ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
title_full_unstemmed ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
title_short ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
title_sort why don t we get counselling comparing nice guidelines for morphological and genetic cancer risk diagnoses
url https://doi.org/10.1002/cam4.70607
work_keys_str_mv AT elspethdavies whydontwegetcounsellingcomparingniceguidelinesformorphologicalandgeneticcancerriskdiagnoses